Miriam J Paramore's Insider Trades & SAST Disclosures
Miriam J Paramore's most recent trade in OptimizeRx Corp was a trade of 15,000 Common Stock Pursuant to 10B5-1 Plan done at an average price of $95.5 . Disclosure was reported to the exchange on Nov. 2, 2021.
Add Superstar Alert
Share
Note
This is a custom search result for pattern Miriam J Paramore.To see full superstar portfolios of large investors like Warren Buffet, Elon Musk and others, click here.
Advanced/Help
"Balanced Fund": Use this format with quotation marks to find the exact phrase. The output matches
"Balanced Fund"
but not "Balanced Growth Fund"
Balanced Fund: Use this format without quotation marks to search for all funds related to the term
"Balanced Fund" The results may include
"Balanced Income Fund", "Balanced Growth Fund" and any fund name containing "Balanced Fund".
| Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
|---|---|---|---|---|---|---|---|---|---|---|
| OptimizeRx Corp | Miriam J. Paramore | PRES. & CHIEF STRATEGY OFFICER | Sale of securities on an exchange or to another person at price $ 95.45 per share. | 02 Nov 2021 | 15,000 | 74,607 (0%) | 0% | 95.5 | 1,431,750 | Common Stock Pursuant to 10B5-1 Plan |
| OptimizeRx Corp | Miriam J. Paramore | PRES. & CHIEF STRATEGY OFFICER | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 02 Nov 2021 | 15,000 | 94,318 | - | - | Stock Option | |
| OptimizeRx Corp | Miriam J. Paramore | PRES. & CHIEF STRATEGY OFFICER | Exercise or conversion of derivative security received from the company (such as an option) at price $ 7.51 per share. | 02 Nov 2021 | 15,000 | 89,607 (0%) | 0% | 7.5 | 112,650 | Common Stock |
| OptimizeRx Corp | Miriam J. Paramore | PRESIDENT AND CSO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 04 Oct 2021 | 15,000 | 109,318 | - | - | Stock Option | |
| OptimizeRx Corp | Miriam J. Paramore | PRESIDENT AND CSO | Sale of securities on an exchange or to another person at price $ 84.67 per share. | 04 Oct 2021 | 15,000 | 74,607 (0%) | 0% | 84.7 | 1,270,050 | Common Stock Pursuant to 10B5-1 Plan |
| OptimizeRx Corp | Miriam J. Paramore | PRESIDENT AND CSO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 7.51 per share. | 04 Oct 2021 | 15,000 | 89,607 (0%) | 0% | 7.5 | 112,650 | Common Stock |
| OptimizeRx Corp | Miriam J. Paramore | PRESIDENT AND CSO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 7.51 per share. | 02 Sep 2021 | 15,000 | 89,607 (0%) | 0% | 7.5 | 112,650 | Common Stock |
| OptimizeRx Corp | Miriam J. Paramore | PRESIDENT AND CSO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 02 Sep 2021 | 15,000 | 124,318 | - | - | Stock Option | |
| OptimizeRx Corp | Miriam J. Paramore | PRESIDENT AND CSO | Sale of securities on an exchange or to another person at price $ 68.39 per share. | 02 Sep 2021 | 15,000 | 74,607 (0%) | 0% | 68.4 | 1,025,850 | Common Stock Pursuant to 10B5-1 Plan |
| OptimizeRx Corp | Miriam J. Paramore | PRESIDENT AND CSO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 7.51 per share. | 02 Aug 2021 | 15,000 | 89,607 (0%) | 0% | 7.5 | 112,650 | Common Stock |
| OptimizeRx Corp | Miriam J. Paramore | PRESIDENT AND CSO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 02 Aug 2021 | 15,000 | 139,318 | - | - | Stock Option | |
| OptimizeRx Corp | Miriam J. Paramore | PRESIDENT AND CSO | Sale of securities on an exchange or to another person at price $ 55.76 per share. | 02 Aug 2021 | 15,000 | 74,607 (0%) | 0% | 55.8 | 836,400 | Common Stock Pursuant to 10B5-1 Plan |
| OptimizeRx Corp | Miriam J. Paramore | PRESIDENT | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 15 Jul 2021 | 71,667 | 154,318 | - | - | Stock Option | |
| OptimizeRx Corp | Miriam J. Paramore | PRESIDENT | Exercise or conversion of derivative security received from the company (such as an option) at price $ 3.15 per share. | 15 Jul 2021 | 67,195 | 74,607 (0%) | 0% | 3.1 | 211,664 | Common Stock |
| OptimizeRx Corp | Miriam J. Paramore | PRESIDENT AND CSO | Sale of securities on an exchange or to another person at price $ 57.81 per share. | 02 Jul 2021 | 15,000 | 7,412 (0%) | 0% | 57.8 | 867,150 | Common Stock Pursuant to 10B5-1 Plan |
| OptimizeRx Corp | Miriam J. Paramore | PRESIDENT AND CSO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 02 Jul 2021 | 15,000 | 225,985 | - | - | Stock Option | |
| OptimizeRx Corp | Miriam J. Paramore | PRESIDENT AND CSO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 3.15 per share. | 02 Jul 2021 | 15,000 | 22,412 (0%) | 0% | 3.2 | 47,250 | Common Stock |
| OptimizeRx Corp | Miriam J. Paramore | PRESIDENT | Exercise or conversion of derivative security received from the company (such as an option) at price $ 3.15 per share. | 04 Jun 2021 | 13,333 | 20,745 (0%) | 0% | 3.2 | 41,999 | Common Stock |
| OptimizeRx Corp | Miriam J. Paramore | PRESIDENT | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 04 Jun 2021 | 13,333 | 240,985 | - | - | Stock Option | |
| OptimizeRx Corp | Miriam J. Paramore | PRESIDENT | Sale of securities on an exchange or to another person at price $ 50.85 per share. | 04 Jun 2021 | 13,333 | 7,412 | - | 50.8 | 677,983 | Common Stock Pursuant to 10B5-1 Plan |
| OptimizeRx Corp | Miriam J. Paramore | PRESIDENT | Sale of securities on an exchange or to another person at price $ 51.30 per share. | 04 Jun 2021 | 1,667 | 7,412 | - | 51.3 | 85,517 | Common Stock Pursuant to 10B5-1 Plan |
| OptimizeRx Corp | Miriam J. Paramore | PRESIDENT | Sale of securities on an exchange or to another person at price $ 42.95 per share. | 17 May 2021 | 15,000 | 9,079 (0%) | 0% | 43.0 | 644,250 | Common Stock |
| OptimizeRx Corp | Miriam J. Paramore | PRESIDENT | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 07 Jan 2021 | 24,093 | 254,318 | - | - | Stock Option |
*All Values are in $ Million
Client Category: Promoter/ KMP/ Director / Immediate Relatives / Employee / etc
Security Type: Share/ Warrants / Convertible Debentures
Security Type: Share/ Warrants / Convertible Debentures
Data as reported to USA Exchanges